Calcitonin antibody and antigen (Recombinant protein)
Diagnostic Calcitonin antibodies (anti-Calcitonin, anti-Calcitonin) and antigens (recombinant Calcitonin protein) for Cancer Calcitonin detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-Calcitonin-Ag01 | Recombinant human CALCA/Calcitonin/CALC1 Protein | 3090 |
GMP-h-Calcitonin-Ab01 | Anti-human CALCA/Calcitonin/CALC1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-Calcitonin-Ab02 | Anti-human CALCA/Calcitonin/CALC1 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-Calcitonin-Ab03 | Anti-human CALCA/Calcitonin/CALC1 human monoclonal antibody (mAb) | 1953 |
GMP-h-Calcitonin-Ab04 | Anti-human CALCA/Calcitonin/CALC1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-Calcitonin-Ag01 |
Product Name | Recombinant human CALCA/Calcitonin/CALC1 Protein |
Target/Biomarker | Calcitonin(Calcitonin) |
Alias of Target/Biomarker | CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT, KC, PCT |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Calcitonin (Calcitonin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Calcitonin level test of Cancer (osteoporosis, hypercalcemia and Parget's diseases) and related syndrome evaluation. |
Products description | Recombinant human CALCA/Calcitonin/CALC1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-Calcitonin-Ab01, GMP-h-Calcitonin-Ab02 |
Product Name | Anti-human CALCA/Calcitonin/CALC1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Calcitonin(Calcitonin) |
Alias of Target/Biomarker | CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT, KC, PCT |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Calcitonin (Calcitonin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Calcitonin (Calcitonin) antibodies in Calcitonin level test of Cancer (osteoporosis, hypercalcemia and Parget's diseases) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human CALCA/Calcitonin/CALC1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-Calcitonin-Ab03, GMP-h-Calcitonin-Ab04 |
Product Name | Anti-human CALCA/Calcitonin/CALC1 human monoclonal antibody (mAb) |
Target/Biomarker | Calcitonin(Calcitonin) |
Alias of Target/Biomarker | CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT, KC, PCT |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human Calcitonin (Calcitonin) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Calcitonin (Calcitonin) antibodies in Calcitonin level test of Cancer (osteoporosis, hypercalcemia and Parget's diseases) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human CALCA/Calcitonin/CALC1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
This test measures the level of calcitonin in your blood. Calcitonin is a hormone made by your thyroid, a small, butterfly-shaped gland located near the throat. Calcitonin helps control how the body uses calcium. Calcitonin is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body. If too much calcitonin is found in the blood, it may be a sign of a type of thyroid cancer called medullary thyroid cancer (MTC). High levels may also be a sign of other thyroid diseases that can put you at a higher risk for getting MTC. These include: C-cell hyperplasia, a condition that causes abnormal growth of cells in the thyroid Multiple endocrine neoplasia type 2 (MEN 2), a rare, inherited disease that causes the growth of tumors in the thyroid and other glands in the endocrine system. The endocrine system is a group of glands that control a variety of important functions, including how your body uses and burns energy (metabolism). Other names: thyrocalcitonin, CT, calcitonin, hCT What is it used for? A calcitonin test is most often used to: Help diagnose C-cell hyperplasia and medullary thyroid cancer Find out if treatment for medullary thyroid cancer is working Find out if medullary thyroid cancer has returned after treatment Screen people with a family history of multiple endocrine neoplasia type 2 (MEN 2). A family history of this disease can put you at a higher risk for developing medullary thyroid cancer.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments